The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of patients with bone-predominant metastatic renal cell carcinoma.
 
Jinesh S. Gheeya
No Relationships to Disclose
 
Mingjia Li
No Relationships to Disclose
 
Menglin Xu
No Relationships to Disclose
 
Danielle Elise Zimmerman
No Relationships to Disclose
 
Katharine A. Collier
Research Funding - Conquer Cancer Foundation
 
Peng Wang
No Relationships to Disclose
 
Edmund Folefac
No Relationships to Disclose
 
Paul Monk
Honoraria - Sanofi/Aventis
Consulting or Advisory Role - Dendreon; Myovant Sciences; Pfizer/NCCN; Sanofi
Speakers' Bureau - Janssen
 
Amir Mortazavi
Honoraria - Motive Medical Intelligence
Consulting or Advisory Role - Debiopharm Group; Pfizer; Seagen
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Debiopharm Group (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Steven K. Clinton
Research Funding - American Cancer Society; American Institute for Cancer Research; Department of Defense-Prostate Cancer Research Program; NIH; The National Cattleman's Beef Association; United States Department of Agriculture
 
Ming Yin
No Relationships to Disclose
 
Yuanquan Yang
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - The whiteoak group
Research Funding - Amgen (Inst); Incyte (Inst); Novartis (Inst)